Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections

Author:

Lei Qing1ORCID,Li Yang2,Hou Hong‐yan3,Wang Feng3,Ouyang Zhu‐qing1,Zhang Yandi1,Lai Dan‐yun2,Banga Ndzouboukou Jo‐Lewis1,Xu Zhao‐wei2,Zhang Bo3,Chen Hong2,Xue Jun‐biao2,Lin Xiao‐song1,Zheng Yun‐xiao2,Yao Zong‐jie1,Wang Xue‐ning2,Yu Cai‐zheng4,Jiang He‐wei2,Zhang Hai‐nan2,Qi Huan2,Guo Shu‐juan2,Huang Sheng‐hai5,Sun Zi‐yong3ORCID,Tao Sheng‐ce2,Fan Xiong‐lin1

Affiliation:

1. Department of Pathogen Biology School of Basic Medicine Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China

2. Shanghai Center for Systems Biomedicine Key Laboratory of Systems Biomedicine (Ministry of Education) Shanghai Jiao Tong University Shanghai China

3. Department of Laboratory Medicine Tongji HospitalTongji Medical CollegeHuazhong University of Science and Technology Wuhan China

4. Department of Public Health Tongji HospitalTongji Medical CollegeHuazhong University of Science and Technology Wuhan China

5. Department of Microbiology School of Basic Medical Sciences Anhui Medical University Hefei China

Funder

Research and Development

Shanghai Jiao Tong University

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. China Daily.WHO declares COVID‐19 a pandemic. Available at:http://www.nytimes.com/2020/03/11/world/coronavirus‐news.htm#link‐682e5b06. Accessed 21 June 2020.

3. WHO.Coronavirus disease (COVID‐2019) situation reports. Available at:https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019/situation‐reports. Accessed 20 June 2020.

4. National Health Commission of the People's Republic of China.COVID‐19 Prevention and Control Plan 3th edition. Available at:http://www.gov.cn/zhengce/zhengceku/2020‐01/29/content_5472893.htm. Accessed June 22 2020.

5. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3